Huntington's Disease Epiomic Insights, 2015-2020

November 2015 | 1 pages | ID: H4DF45AD370EN
Black Swan Analysis limited

Abstracts

Epiomic Insights for Huntington’s disease (HD) provides you with a top line snapshot of the market potential for this progressive neurodegenerative disorder. Individuals inheriting the gene can manifest symptoms at any point in life making it extremely difficult to quantify an accurate eligible patient population that can be addressed by a new innovative treatment.

Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant clinical trial data and patient registries to provide a picture of the total projected prevalent population across 8 major global markets.

This one-page synopsis developed by our team of analysts delivers a current overview of the disease and risk factors with a perspective on the future drivers of the patient population. The total HD population across all markets has also been segmented by gender type and the 3 most prevalent psychiatric disorders.

This style of report is ideal for companies entering a new market segment or disease area of which they have limited knowledge. Alternatively, companies considering investing in healthcare innovation may benefit from a high-level, accurate overview of the market to determine likely commercial potential of such an investment.